Search

Houston Oncology Summit: Oppenheimer analysts Jeff Jones and Jay Olson talk radiopharmaceuticals and antibody-drug conjugates
Jeff Jones notes how radioisotopes are being added to more than just antibodies, and calls out upcoming data from Perspective...
Sep 26, 2024

Houston Oncology Summit: Oppenheimer analyst Jeff Jones on the growth of radiopharmaceuticals
Jeff Jones describes the science behind radiopharmaceuticals and how both new targets and better isotopes are making them more effective.
Sep 21, 2023